Search

Your search keyword '"Aine McKillop"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Aine McKillop" Remove constraint Author: "Aine McKillop"
40 results on '"Aine McKillop"'

Search Results

1. Zinc-induced activation of GPR39 regulates glucose homeostasis through glucose-dependent insulinotropic polypeptide secretion from enteroendocrine K-cells

2. Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice

3. Development of novel ligands for peptide GPCRs

4. Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice

5. Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis

6. GPR39 receptors and actions of trace metals on pancreatic beta cell function and glucose homoeostasis

7. Tissue expression of DPP-IV in obesity-diabetes and modulatory effects on peptide regulation of insulin secretion

8. Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreaticβ-cells

9. Evidence for inhibitory autocrine effects of proinsulin C-peptide on pancreaticβ-cell function and insulin secretion

10. An evaluation of resource development and dissemination activities designed to promote problem-based learning at the University of Ulster

11. Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice

12. Emerging Applications of Metabolomic and Genomic Profiling in Diabetic Clinical Medicine

13. Insulinotropic actions of nateglinide in type 2 diabetic patients and effects on dipeptidyl peptidase-IV activity and glucose-dependent insulinotropic polypeptide degradation

14. Effect of RU486 on Hepatic and Adipocyte Gene Expression Improves Diabetes Control in Obesity-type 2 Diabetes

15. Recent Developments in the Search for Biomarkers for the Diagnosis and Monitoring of Diabetes

16. Sub-chronic administration of the 11β-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity

17. G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis

19. Meal-dependent Regulation of Circulating Glycated Insulin in Type 2 Diabetic Subjects

20. Meal-induced 24-hour profile of circulating glycated insulin in type 2 diabetic subjects measured by a novel radioimmunoassay

21. Evaluation of the site(s) of glycation in human proinsulin by ion-trap LCQ electrospray ionization mass spectrometry

22. Demonstration of increased concentrations of circulating glycated insulin in human Type 2 diabetes using a novel and specific radioimmunoassay

23. Demonstration of Glycated Insulin in Human Diabetic Plasma and Decreased Biological Activity Assessed by Euglycemic-Hyperinsulinemic Clamp Technique in Humans

24. Evaluation of Glycated Insulin in Diabetic Animals Using Immunocytochemistry and Radioimmunoassay

25. Structure, antihyperglycemic activity and cellular actions of a novel diglycated human insulin

26. Production and characterization of specific antibodies for evaluation of glycated insulin in plasma and biological tissues

27. Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice

28. Evaluation of the degradation and metabolic effects of the gut peptide xenin on insulin secretion, glycaemic control and satiety

29. Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects

30. Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1

31. Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes

32. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

33. Effects of nateglinide on the secretion of glycated insulin and glucose tolerance in type 2 diabetes

34. Evaluation of glycated glucagon-like peptide-1(7-36)amide in intestinal tissue of normal and diabetic animal models

35. Degradation and glycemic effects of His(7)-glucitol glucagon-like peptide-1(7-36)amide in obese diabetic ob/ob mice

36. Impaired ability of glycated insulin to regulate plasma glucose and stimulate glucose transport and metabolism in mouse abdominal muscle

39. Metformin inhibits dipeptidyl peptidase IV activity in type 2 diabetes

Catalog

Books, media, physical & digital resources